Partner Fund Management »

Personalis Ord shares owned by Partner Fund Management

Quarter-by-quarter ownership of Personalis Ord (PSNL) shares owned by Partner Fund Management from 13F filings

Historical chart of Partner Fund Management investment in Personalis Ord

Tip: Access up to 7 years of quarterly data

All positions including Personalis Ord held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Personalis Ord by Partner Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.4M 806k 7.96

More positions owned by Partner Fund Management

Tenet Healthcare Corp Com New (THC)
Eli Lilly & Co. (LLY)
Axsome Therapeutics (AXSM)
Centene Corporation (CNC)
Penumbra (PEN)
Ascendis Pharma A/s Sponsored Adr (ASND)
United Therapeutics Corporation (UTHR)
Bridgebio Pharma (BBIO)
Adma Biologics (ADMA)
Neurocrine Biosciences (NBIX)
Glaukos (GKOS)
Thermo Fisher Scientific (TMO)
Edwards Lifesciences (EW)
Icon SHS (ICLR)
Inhibrx Biosciences (INBX)

View all positions for Partner Fund Management

Top funds holding Personalis Ord

Merck & Co
T. Rowe Price Investment Management
Lightspeed Management Company
ARK Investment Management
Ameriprise Financial
BlackRock
Vanguard Group
Standard Life Aberdeen
AIGH Capital Management
Kennedy Capital Management
Blue Water Life Science Advisors
Geode Capital Management
State Street Corporation
Dimensional Fund Advisors
Partner Fund Management

View all funds holding Personalis Ord